RIGHT Foundation commits additional 11.3 billion KRW to innovative infectious disease R&D projects for global public health
RIGHT Foundation commits additional 11.3 billion KRW to innovative infectious disease R&D projects for global public health RIGHT Foundation (Research Investment for Global Health Technology Foundation) has announced the recipients of its Product Development Award and the Evidence Generation Award from the 2022 Request for Proposals (RFP). Th...
RIGHT Fund opens its first Request for Proposal for 2022
This article is only available in Korean. Original Article Press Release List
RIGHT Fund commits additional 13.6 billion KRW to innovative infectious disease R&D projects
RIGHT Fund (CEO Younbeen Kim / Research Investment for Global Health Technology Fund) has announced its selection of 2021 research grant award recipients for an additional funding of 13.6 billion KRW. The RIGHT Fund is a global health research funding foundation established in 2018 through the public-private partnership between the Ministry of He...
Taking equal accessibility and virus variants into consideration in prioritizing vaccine R&D
This article is only available in Korean. Original Article Press Release List
KT Joins RIGHT Fund as new industrial funder
This article is only available in Korean. Original Article Press Release List
Dr. Myongsei Sohn was Elected as the New Chairman of the Board of Directors, RIGHT Fund
This article is only available in Korean. Original Article Press Release List
RIGHT Fund Announces its 5th Request for Proposal for Infectious Diseases Research
OSupport R&D Projects for Vaccines, Therapeutics, Diagnostics and Digital Health Tackling Endemic and Emerging Infectious Diseases in Developing Countries Briefing Session to be Held at the RIGHT Fund Investment Forum 2020 on 12th Nov Seoul, Republic of Korea, November 12th, 2020 – The RIGHT Fund (Younbeen Kim, CEO) announces a new request for...
RIGHT Fund Investment Forum 2020 will be held online and offline on Nov 12th
This article is only available in Korean. Original Article Press Release List
PLOS NTD Shedding Light on RIGHT Fund as Korea’s new Funding Agency to Advance Innovative Neglected Disease Technologies
Seoul, Republic of Korea, September 28th, 2020 – The RIGHT Fund (Younbeen Kim, CEO) was introduced as a new R&D funding agency in South Korea to lead innovative technological advances in neglected diseases in the September issue of PLOS Neglected Tropical Diseases, an internationally acclaimed journal published by the Public Library of Science...
Bioneer Joins RIGHT Fund as new industrial funder
This article is only available in Korean. Original Article Press Release List
EuBiologics Joins RIGHT Fund as new industrial funder
This article is only available in Korean. Original Article Press Release List
SD BIOSENSOR Joins RIGHT Fund as new industrial funder
This article is only available in Korean. Original Article Press Release List
RIGHT Fund Supports KRW 18B Additionally in 17 R&D Projects for Infectious Disease Including R&D Projects for COVID-19 Vaccine
Established the portfolio of 22 technologies tackling infectious diseases worth KRW 28.5 billion by selecting additional projects for this year R&D on respiratory infectious diseases including COVID-19 has become the biggest part of the investment portfolio… Request for Proposals for new R&D projects is ongoing Seoul, Republic of Korea, J...
RIGHT Fund Announces a New Request For Proposals Tackling Infectious Diseases Including COVID-19
2nd Request for Proposals for Mid-to-Large Projects of This Year is Ongoing to Fight Against Infectious Diseases in Developing Countries, Following the Small Project Award in March A Web-seminar Regarding the New RFP to be Held on June 12 th on the Official Website Seoul, Republic of Korea, June 3rd, 2020 – The RIGHT Fund (Younbeen...
KHIDI-RIGHT Fund sign MOU to promote research on health care technologies for infectious diseases
This article is only available in Korean. Original Article Press Release List
NECA-RIGHT Fund establish a cooperation system to support new medical technologies for infectious diseases
This article is only available in Korean. Original Article Press Release List
RIGHT Fund expands support for Infectious Diseases research
Invest in R&D projects for vaccines, therapeutics and diagnostics tackling infectious diseases in developing countries including COVID-19 Total three calls for proposals this year, including newly added Technical Accelerator Awards for small projects Seoul, Republic of Korea, 10TH March 2020 – The RIGHT Fund (Research Investment for Global Hea...
“Need to further facilitate public-private partnership for public health investment”
Younbeen Kim, CEO of RIGHT Fund, Participated in DCVMN General Assembly on October 21~23th Younbeen Kim, CEO of RIGHT Fund emphasizes the need for public-private partnership such as RIGHT Fund to promote the development of vaccines for public interest. This article is only available in Korean. Original Article Press Release List